News|Articles|September 13, 2025

Top 5 Infectious Disease News Stories Week of September 6-13

Author(s)Sophia Abene

This week, US measles totals reached 1,454, a 750-plus-day SARS-CoV-2 infection in a person with HIV informed care, implementation science efforts advanced access, and a universal flu adjuvant showed promise.

At ASM Microbe, Jacinda C. Abdul-Mutakabbir, PharmD, MPH (University of California San Diego), reported that social determinants of health such as poverty, underinsurance, and transportation barriers, together with limited health literacy, reduce engagement with care, delay diagnosis, and contribute to noncommunicable diseases (NCDs) and subsequent infection risk, including health care associated infections. Citing her recent publication in Infectious Diseases and Therapy, she described a syndemic relationship between NCDs and multidrug-resistant infections observed in low- and middle-income countries and in parts of the United States. She called for prevention to receive equal priority with treatment and outcomes and highlighted a persistent gap in translation to practice. She recommended linking bench findings with clinical outcomes and patient sociodemographic data, for example mapping isolates and biologic mechanisms to therapeutic response, comorbidities, and population characteristics, to guide prevention and clinical management.

Related to this article

IDSA/ESCMID Statement on Staphylococcus aureus: Follow-Up Blood Cultures
IDSA and ESCMID released 7 consensus statements to assist in managing individuals with SAB. This review will focus on the adult patient population and additional information on pediatric population statements can be assessed in the guideline. Here is a closer look at Consensus Statement 2: Follow-up Blood Cultures.